Authors : Dr. P. Rajendra Kumar

Volume/Issue : Volume 10 - 2025, Issue 1 - January

Google Scholar : https://tinyurl.com/5bhzvc5f

Scribd : https://tinyurl.com/2s3t88wh

DOI : https://doi.org/10.5281/zenodo.14836646

Abstract : Background: Acute ischemic stroke (AIS) is a leading cause of morbidity and mortality worldwide. Serum albumin levels have been proposed as a potential prognostic indicator for functional outcomes in stroke patients.  Objective: This study aims to evaluate the role of serum albumin levels as a prognostic indicator of acute ischemic stroke, using the modified Rankin scale (mRS) at a 3-month follow-up.  Methods: A cross-sectional study was conducted over 18 months at Katuri Medical College, involving 100 patients diagnosed with AIS within the first 72 hours of symptom onset. Clinical and biochemical parameters, including serum albumin levels, were assessed. The severity of stroke was measured using the Scandinavian Stroke Scale (SSS) and outcomes were evaluated using the mRS.  Results: The study found that 35% of patients had moderate disability, 26% had mild disability, and 9% died. A significant association was observed between low serum albumin levels and increased stroke severity, with lower albumin levels correlating with poorer functional outcomes at 3 months. The mean serum albumin level was significantly lower in patients with severe disability compared to those with mild disability.  Conclusion: Serum albumin levels are significantly associated with the severity of acute ischemic stroke and can serve as a useful prognostic marker for predicting functional outcomes. Monitoring serum albumin levels in stroke patients may help in assessing their nutritional status and guiding treatment strategies. Further studies are warranted to explore the therapeutic implications of albumin supplementation in stroke management.

References :

1. Mozaffarian D, et al. Heart disease and stroke statistics—2015 update: a report  from  the  American  Heart  Association.  Circulation. 2015:e29– 322. [PubMed] [Google Scholar]
2. Gresham GE,  et  al.  Residual  capacity  in  survivors  of  stroke:  the Framingham study. N Engl J Med. 1975;293:954–956. [PubMed] [Google Scholar]
3. Duncan PW, et al. Measurement of motor recovery after stroke: outcome assessment  and  sample  size  requirements.  Stroke.   1992;23:1084–1089. [PubMed] [Google Scholar]
4. Paolucci  S,  et  al.  Functional  outcome  of  ischemic  and  hemorrhagic stroke      patients      after       inpatient      rehabilitation      A       matched comparison. Stroke. 2003;34:2861–2865. [PubMed] [Google Scholar]
5. Pandian JD, et al. Premorbid nutrition and short term outcome of stroke: a      multicentre      study      from       India.      J      Neurol      Neurosurg Psychiatry. 2011;82:1087–1092. [PubMed] [Google Scholar]
6. Quinlan  GJ,  et  al.  Albumin:   biochemical  properties  and  therapeutic potential.    Hepatology.    2005;41(6):1211–1219.     [PubMed]    [Google Scholar]
7. Kirsch  R,  et  al.  Regulation  of  albumin  synthesis  and  catabolism  by alteration        of        dietary        protein.        Nature.         1968;217:578–579. [PubMed] [Google Scholar]
8. https://www.researchgate.net/publication/46218340_Three_periods_of_one_and_a_half_decade_of_ischemic_stroke_susceptibility_gene_resear  ch_Lessons_we_have_learned
9. Kumral  E,  Bayulkem  G,  Evyapan  D,  Yunten  N.  Spectrum  of  anterior cerebral  artery  territory  infarction:  clinical  and  MRI  findings.  Eur  J Neurol. 2002 Nov;9(6):615-24. [PubMed]
10. Brandt  T,  Steinke  W, Thie A,  Pessin  MS,  Caplan  LR.  Posterior cerebral  artery  territory  infarcts:  clinical  features,   infarct  topography, causes   and   outcome. Multicenter   results    and   a    review   of   the literature. Cerebrovasc Dis. 2000 May-Jun;10(3):170-82. [PubMed]
11. Cereda    C,    Carrera    E.    Posterior    cerebral    artery    territory infarctions. Front Neurol Neurosci. 2012;30:128-31. [PubMed]
12. Jensen   MB,   St   Louis   EK.   Management   of   acute   cerebellar stroke. Arch Neurol. 2005 Apr;62(4):537-44. [PubMed]
13. Aldrich  MS, Alessi AG,  Beck  RW, Gilman  S. Cortical blindness: etiology,  diagnosis,  and  prognosis.  Ann  Neurol.  1987  Feb;21(2):149-58. [PubMed]
14. Birenbaum D, Bancroft   LW,   Felsberg   GJ.   Imaging   in   acute stroke. West J Emerg Med. 2011 Feb;12( 1):67-76.
15. Seshad ri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB,  Wolf   PA.  The  lifetime  risk  of  stroke:   estimates  from  the Framingham Study. Stroke. 2006 Feb;37(2):345-50. [PubMed]
16. Carandang R, Seshad ri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends  in  incidence,  lifetime  risk,  severity,  and 30-day mortality of stroke over the past 50 years. JAMA. 2006 Dec 27;296(24):2939-46. [PubMed]
17. Peters   TJ.   All    about   albumin.   San    Diego:   Academic; 1996. [Google Scholar]
18. Doweiko  JP,  Nompleggi  DJ:  The  role  of  albumin  in  human physiology  and  pathophysiology,  part  III:  Albumin   and  disease states. J Parenter Enteral Nutr 15(4):476–483, 1991. 10. Rothschild MA, Oratz M, Schreiber SS: Albumin synthesis (first of two parts). N Eng J  Med 286( 14):748–757,  1972.  11.  Rothschild  MA,  Oratz  M, Schreiber  SS:  Albumin  metabolism.  Gastroenterology  64(2):324– 337,  1973.  12.  Rothschild  MA,  Oratz  M,  Schreiber  SS:  Albumin synthesis  (second of two  parts).  N  Eng  J  Med  286( 15):816–821,1972
19. Bruegger D, Jacob M, Scheingraber S, Conzen P, Becker BF, Finsterer U, Rehm M. Changes in acid-base balance following bolus infusion of 20% albumin solution in humans.  Intensive Care Med. 2005  Aug;31(8):1123-7.  doi:   10.1007/s00134-005-2683-4.   Epub 2005 Jul 6. Erratum in:  Intensive Care  Med. 2006 Mar;32(3):483. PMID: 15999255.
20. Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care. 2013 Feb 15;3( 1):4.  doi:  10.1186/2110-5820-3-4.  PMID:  23414610;  PMCID: PMC3577569.
21. Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the   preservation    of   endothelial    glycocalyx   integrity    and   the microcirculation:   a    review.   Ann    Intensive    Care.    2020    Jun 22;10( 1):85.  doi:  10.1186/s13613-020-00697-1.  PMID:  32572647; PMCID: PMC7310051.
22. Paar M, Rossmann C, Nusshold C, Wagner T, Schlagenhauf A,  Leschnik  B,  Oettl  K,  Koestenberger  M,  Cvirn  G,  Hallströ m  S. Anticoagulant action of low, physiologic, and high albumin levels in whole   blood.   PLoS   One.   2017   Aug    11;12(8):e0182997.   doi: 10.1371/journal.pone.0182997.      PMID:       28800610;       PMCID: PMC5553770.
23. Ludmila  Belayev, Liu Y, Zhao W, Busto R, Ginsberg MD. Human Albumin     Therapy     of    Acute      Ischemic     Stroke.     Stroke.     2001 Feb 1;32(2):553–60.
24. Yuwen  P, Chen W, Lv  H, Feng C, Li Y, Zhang T, Hu P, Guo J, Tian Y, Liu L, Sun J, Zhang Y. Albumin and surgical site infection risk in orthopaedics: a meta-analysis. BMC Surg. 2017 Jan  16;17( 1):7. [PMC free article] [PubMed]
25. Chang  R,  Holcomb  JB.  Choice  of  Fluid  Therapy  in  the   Initial Management of Sepsis, Severe Sepsis, and Septic Shock. Shock. 2016 Jul;46( 1):17-26. [PMC free article] [PubMed]
26. Rothschild       MA,       Oratz      M,      Schreiber       SS.       Serum albumin. Hepatology. 1988 Mar-Apr;8(2):385-401. [PubMed]
27. Annane  D, Siami S, Jaber S, Martin C,  Elatrous S, Declè re AD, Preiser JC, Outin H, Troché G, Charpentier C, Trouillet JL, Kimmoun A, Forceville X, Darmon M, Lesur O, Reignier J, A broug F, Berger P, Clec'h C, Cousson J, Thibault L, Chevret S., CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013 Nov 06;310( 17):1809-17. [PubMed]
28. Dash  PK,  Behera  S,  Sahoo  NC,  Rattan  R,  Tripathy  SK.  Serum albumin level as prognostic indicator of acute ischemic stroke in tertiary care  hospital  admitted  patients.  International  Journal  of  Advances  in Medicine. 2020 May 22;7(6):948.
29. Dziedzic  T,  Slowik  A,  Szczud lik  A.  Serum  albumin  level  as  a predictor of  ischemic  stroke  outcome.  Stroke.  2004  Jun;35(6):e156-8. doi: 10.1161/01.STR.0000126609.18735.be. Epub 2004 Apr 8. Erratum in: Stroke. 2005 Mar;36(3):689. PMID: 15073386.
30. Thacker  S,  Shrijikumar C, Thakkar, Tanna  P,  Baghel  R.  Serum Albumin  Level  as  a  Prognostic  Indicator  of  Acute   Ischemic   Stroke [Internet]. [cited 2024 Jul 18].
31. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-  reactive protein, albumin, or leukocyte count with coronary heart disease: meta analyses of prospective studies. JAMA. 1998;279( 18):477–1482.[PubMed] [Google Scholar]
32. Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. [PubMed] [Google Scholar]
33. Abu bakar  S,  Sab ir  A,   Ndakotsu   M,   Imam   M,  Tasiu  M.  Low admission  serum  albumin  as  prognostic  determinant  of  30-day  case fatality and adverse functional outcome following acute ischemic stroke. Pan Afr Med J. 2013;14:53. doi: 10.11604/pamj.2013.14.53.1941. Epub 2013 Feb 7. PMID: 23565300; PMCID: PMC3617615.
34. Che, R., Huang, X., Zhao, W. et al. Low Serum Albumin level as a Predictor of Hemorrhage Transformation after Intravenous Thrombolysis in Ischemic Stroke Patients. Sci Rep 7, 7776 (2017).
35. Davalos A, Ricart W, Gonzalez-Huix F, et al. Effect of malnutrition after acute stroke on clinical outcome.  Stroke.  1996;27(6):1028–1032. [PubMed] [Google Scholar]
36. Dziedzic  T,  Pera  J,  Slowik  A,  et  al.  Hypoalbuminemia  in  acute ischemic  stroke  patients:  frequency  and  correlates.  Eur  J  Clin  Nutr. 2007;61:1318–1322. [PubMed] [Google Scholar]
37. Dziedzic  T,  Slowik  A,  Szczud lik  A.  Serum  albumin  level  as  a predictor  of  ischemic  stroke  outcome.  Stroke.  2004;35(8):156–158. [PubMed] [Google Scholar]
38. Chakraborty B, Vishnoi G, Goswami B, et al. Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of  acute ischemic stroke in North Indian Patients. J Stroke Cerebrovasc Dis. 2013;22(7):e159–67. [PubMed] [Google Scholar]
39. Ginsberg M, Palesch Y, Hill M, et al. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, Phase  3,  placebo-controlled  trial.  Lancet  Neurol.  2013;12( 11):1049–1058. [PMC free article] [PubMed] [Google Scholar]
40. Rocha  M,  Jovin  T.  Fast  versus  slow  progressors  of  infarct growth  in  large  vessel  occlusion  stroke:  clinical  and  research implications.   Stroke.   2017;48(9):2621–2627.   [PubMed]   [Google Scholar]
41. Löwhagen    Hendén     P,    Rentzos    A,    Karlsson    JE,    et al. Hypotension during endovascular treatment of ischemic stroke is a     risk     factor     for     poor     neurological     outcome.      Stroke. 2015;46(9):2678–2680. [PubMed] [Google Scholar]
42. Jagani  M,  Brinjikji  W,  Rabinstein  A,  et  al.  Hemodynamics during   anesthesia   for   intra-arterial   therapy   of   acute   ischemic stroke. J Neurointerv Surg. 2016;8(9):883–888. [PubMed] [Google Scholar]
43. Maalej   N,  Albrecht   R,   Loscalzo  J,  et  al.  The  potent  platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol. 1999;33(5):1408–1414. [PubMed] [Google Scholar]
44. George  G,  Alastair  GS.  Albumin  inhibits  platelet-activating factor  (PAF)-induced  responses  in  platelets  and  macrophages: implications for the biologically active form of PAF. Br J Pharmacol. 1992;107( 1):73–77. [PMC free article] [PubMed] [Google Scholar]
45. Belayev  L,   Pinard  E,   Nallet  H,  et  al.  Albumin  therapy  of transient  focal  cerebral  ischemia:  in  vivo  analysis  of  dynamic microvascular       responses.       Stroke.      2002;33(4):1077–1084. [PubMed] [Google Scholar]
46. Remmers  M,  Schmidt-Kastner  R,  Belayev  L,  et  al.  Protein extravasation  and  cellular  uptake  after  high-dose  human-albumin treatment  of transient focal  cerebral  ischemia  in  rats.  Brain  Res. 1999;827( 1–2):237–242. [PubMed] [Google Scholar]
47. Zhou  H, Wang A, Meng X, Lin J, Jiang Y, Jing J, et al. Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack. Stroke and Vascular Neurology [Internet]. 2021 Feb 25 [cited 2024 Feb 23];6(3):458–66
48. Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M, Liu L, Wang H, Yin Q, Liu X. Serum Albumin Levels and Clinical Outcomes Among  Ischemic  Stroke     Patients      Treated     with      Endovascular      Thrombectomy. Neuropsychiatr      Dis     Treat.      2021      Feb      10;17:401-411.      doi: 10.2147/NDT.S293771. PMID: 33603378; PMCID: PMC7882440.
49. Wang, Yu  MMa,b,c,d,e; Zhuang, Yangping  MDa,b,c,d,e;  Huang, Hanlin      MMa,b,c,d,e;      Ke,      Jun       MDa,b,c,d,e;      Lin,      Shirong MDa,b,c,d,e; Chen,  Feng  MBa,b,c,d,e,*. Association of serum albumin levels and stroke risk in adults over 40 years: A population-based study. Medicine     102(36):p     e34848,     September     08,     2023. DOI: 10.1097/MD.0000000000034848
50. Aptaker  RL,  Roth  EJ,  Reichhardt  G,  Duerden  ME,  Levy  CE. Serum  albumin  level  as  a  predictor  of  geriatric  stroke  rehabilitation outcome. Arch Phys Med Rehab il. 1994 Jan;75( 1):80-4. PMID: 8291969.
51. Gariballa SE,  Parker SG, Taub N, Castleden CM.  Influence of nutritional status   on   clinical   outcome   after   acute   stroke.   Am   J   Clin   Nutr.    1998 Aug;68(2):275-81. doi: 10.1093/ajcn/68.2.275. PMID: 9701183.
52. Babu MS, Kaul S, Dad heech S, Rajeshwar K, Jyothy A, Munshi A. Serum albumin  levels  in  ischemic  stroke  and  its  subtypes:  correlation  with  clinical outcome. Nutrition. 2013;29(6):872-5.
53. Ramesh  VG.   Bedside  computed  tomography   in  traumatic   brain  injury. Neurol India 2016. 2019; 64:12-3.
54. James R, Antony J, Sreed har S, Mathew R, Surend ran A. study of serum albumin as a  predictor of short-term functional outcome  in acute  ischaemic stroke  J.   Evolution  Med  Dent  Sci.  2278-4802.   16.   Kasundra  G,  Sood  I. Prognostic Significance Of Serum Albumin Levels  In Acute  Ischemic Stroke. Natl J Integr Res Med. 2014;5:1-4.
55. Reinhardt  GF,  Myscofski  JW,  Wilkens  DB,  Dobrin  PB,  Mangan  JE  Jr, Stannard   RT.   Incidence   and    mortality   of   hypoalbuminemic    patients   in hospitalized  veterans.  JPEN  J  Parenter  Enteral  Nutr.   1980;4(4):357–359. doi: 10.1177/014860718000400404. [PubMed] [CrossRef] [Google Scholar]